Estrella Immunopharma(ESLA) - Prospectus

As filed with the U.S. Securities and Exchange Commission on October 10, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 5858 Horton Street, Suite 170 Emeryville, California, 95608 Telephone: (510) 318-9098 (Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant's Principal Executive Offices) ––––––––––––––––––––––––––––– Cheng Liu Chief Executive Officer 5858 Ho ...